Genpharmasec Ltd Submits FY26 Annual Report and AGM Notice

Genpharmasec Limited has submitted its Annual Report for the Financial Year 2025-26, along with the Notice of the 34th Annual General Meeting (AGM). The report details the audited standalone and consolidated financial statements for the year ended March 31, 2026. The AGM will be held on September 29, 2026, via video conferencing to adopt these financial statements and appoint a director. The company is distributing the report electronically to members with registered email addresses and providing a web-link for others. The Annual Report and AGM Notice are also available on the company's website.